Literature DB >> 26445774

T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.

Isabel Almeida1,2, Sara Vieira Silva3, Ana Raquel Fonseca4, Ivone Silva5,6, Carlos Vasconcelos7,8, Margarida Lima9,10.   

Abstract

Scleroderma (SSc) is a rare and heterogeneous immune-mediated disease involving the connective tissue and microvasculature whose pathogenesis remains unclear. Data concerning T and natural killer (NK) cell abnormalities and cytokine levels in the peripheral blood (PB) from patients with SSc are scarce, and the results are contradictory. The present study aimed to analyze the changes of T lymphocytes, NK cells, and T helper (Th)-related cytokines in the PB of patients with SSc in comparison to healthy individuals and its relation to disease subtype and stage, organ involvement, and nailfold capillaroscopic changes. A non-random convenience sample of 57 scleroderma patients was utilized. Fifty-five out of the 57 patients studied were women (97 %); 10 patients presented pre-scleroderma (pre-SSc) and 47 SSc: 34 limited cutaneous SSc (lcSSc) and 13 diffuse cutaneous SSc (dcSSc). Patients with SSc were classified in early (n = 7), intermediate (n = 10), and late (n = 30) disease. Blood samples were analyzed by flow cytometry for total T cells, CD4+ and CD8+ T cell subsets, total NK cells, and CD56+low and CD56+high NK cell subsets. T cells were further analyzed for the expression of the CD56 adhesion molecule and activation-related markers (HLA-DR, CD45RO). In addition, the serum levels of Th1-, Th2-, and Th17-related cytokines were measured by flow cytometry. Twenty-five healthy individuals recruited from the blood bank were used as controls. Patients had lower numbers of total lymphocytes and T cells comparing to healthy controls. Both CD4+ and CD8+ T cells were decreased, but differences were statistically significant only for CD8+ and CD8+ CD45RO+ T cells. These alterations were seen in patients with SSc but not in patients with pre-SSc, and, in general, they were more pronounced in patients with dcSSc than in patients with lcSSc, in patients with vascular involvement than in those without, as well as in patients having active and late nailfold capillaroscopic patterns. CD56+ T cells were also decreased in SSc patients, especially in those with active/late capillaroscopic patterns or with severe lung disease. Diminished numbers of circulating NK cells were also observed in patients with lcSSc and in those with early disease. No statistically significant changes were found in serum cytokine levels, as compared with controls. Patients with SSc had major alterations in circulating CD8+ and CD56+ T cells, as well as in NK cells, suggesting that these cells may play a relevant role in SSc pathogenesis, probably operating at different phases and/or at different organs. In addition, the serum levels of Th1, Th2, and Th17 cytokines did not provide useful information for evaluating T cell polarization in SSc.

Entities:  

Keywords:  CD4; CD56; CD8; Cytokines; NK cells; Systemic sclerosis; T cells

Mesh:

Substances:

Year:  2015        PMID: 26445774     DOI: 10.1007/s12016-015-8505-8

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  113 in total

Review 1.  New insights into the pathogenesis of systemic sclerosis.

Authors:  Mathieu C Tamby; Youri Chanseaud; Loïc Guillevin; Luc Mouthon
Journal:  Autoimmun Rev       Date:  2003-05       Impact factor: 9.754

2.  Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?

Authors:  Maki Murata; Manabu Fujimoto; Takashi Matsushita; Yasuhito Hamaguchi; Minoru Hasegawa; Kazuhiko Takehara; Kazuhiro Komura; Shinichi Sato
Journal:  J Dermatol Sci       Date:  2008-03-07       Impact factor: 4.563

3.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

Review 4.  Review: evidence that systemic sclerosis is a vascular disease.

Authors:  Marco Matucci-Cerinic; Bashar Kahaleh; Fredrick M Wigley
Journal:  Arthritis Rheum       Date:  2013-08

Review 5.  Cytokines in acute and chronic inflammation.

Authors:  C A Feghali; T M Wright
Journal:  Front Biosci       Date:  1997-01-01

6.  Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis.

Authors:  V V Yurovsky; F M Wigley; R A Wise; B White
Journal:  Hum Immunol       Date:  1996 Jun-Jul       Impact factor: 2.850

7.  Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment.

Authors:  J Domagała-Kulawik; G Hoser; A Doboszyńska; J Kawiak; W Droszcz
Journal:  Respir Med       Date:  1998-11       Impact factor: 3.415

Review 8.  Autoimmunity in systemic sclerosis: current concepts.

Authors:  Francesco Boin; Antony Rosen
Journal:  Curr Rheumatol Rep       Date:  2007-05       Impact factor: 4.592

Review 9.  Interleukin-17 in human inflammatory diseases.

Authors:  Arezoo Gowhari Shabgah; Ebrahim Fattahi; Fatemeh Zare Shahneh
Journal:  Postepy Dermatol Alergol       Date:  2014-09-08       Impact factor: 1.837

10.  Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease.

Authors:  José Manuel López-Cacho; Soledad Gallardo; Manuel Posada; Miriam Aguerri; David Calzada; Teodoro Mayayo; María Luisa González-Rodríguez; Antonio María Rabasco; Carlos Lahoz; Blanca Cárdaba
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

View more
  12 in total

1.  Decreased A20 expression on circulating CD56bright NK cells contributes to a worse disease status in patients with ankylosing spondylitis.

Authors:  M Yang; Y Zhou; L Liu; S Wang; J Jiang; Q Shang; H Yu; X Xiang; X Pang; T Li; P Zhao
Journal:  Clin Exp Immunol       Date:  2019-06-30       Impact factor: 4.330

Review 2.  Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.

Authors:  Laurent Simonin; Elisabeth Pasquier; Christophe Leroyer; Divi Cornec; Julie Lemerle; Boutahar Bendaoud; Sophie Hillion; Jacques-Olivier Pers; Francis Couturaud; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 3.  Autoimmunity in 2015.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

4.  Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis.

Authors:  Michelle Fleury; Anna C Belkina; Elizabeth A Proctor; Christopher Zammitti; Robert W Simms; Douglas A Lauffenburger; Jennifer E Snyder-Cappione; Robert Lafyatis; Hans Dooms
Journal:  Arthritis Rheumatol       Date:  2018-03-07       Impact factor: 10.995

Review 5.  CD56 in the Immune System: More Than a Marker for Cytotoxicity?

Authors:  Heleen H Van Acker; Anna Capsomidis; Evelien L Smits; Viggo F Van Tendeloo
Journal:  Front Immunol       Date:  2017-07-24       Impact factor: 7.561

Review 6.  Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist's, Clinician's, and Patient's Perspective.

Authors:  Marta Cossu; Lorenzo Beretta; Petra Mosterman; Maria J H de Hair; Timothy R D J Radstake
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

7.  Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment.

Authors:  Olga Gumkowska-Sroka; Krystyna Jagoda; Aleksander Owczarek; Grzegorz Helbig; Joanna Giemza-Stokłosa; Przemysław J Kotyla
Journal:  J Clin Med       Date:  2019-05-08       Impact factor: 4.241

8.  KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico.

Authors:  Andrea Carolina Machado-Sulbaran; María Guadalupe Ramírez-Dueñas; José Eduardo Navarro-Zarza; José Francisco Muñoz-Valle; Francisco Mendoza-Carrera; Christian Johana Baños-Hernández; Isela Parra-Rojas; Margarita Montoya-Buelna; Pedro Ernesto Sánchez-Hernández
Journal:  J Immunol Res       Date:  2019-01-06       Impact factor: 4.818

9.  Identification of Potential ceRNA Network and Patterns of Immune Cell Infiltration in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Qiuhong Wu; Yang Liu; Yan Xie; Shixiong Wei; Yi Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-17

10.  Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release.

Authors:  Audrey Benyamine; Jérémy Magalon; Florence Sabatier; Luc Lyonnet; Stéphane Robert; Chloé Dumoulin; Sophie Morange; Karin Mazodier; Gilles Kaplanski; Martine Reynaud-Gaubert; Pascal Rossi; Françoise Dignat-George; Brigitte Granel; Pascale Paul
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.